Early protection in sheep against intratypic heterologous challenge with serotype O foot-and-mouth disease virus using high-potency, emergency vaccine

Vaccine

Volumn 33, Issue 3, 2015, Pages 422-429

  Horsington, Jacquelyn ^a   Zhang, Zhidong ^b   Bittner, Hilary ^b   Hole, Kate ^b   Singanallur, Nagendrakumar B ^a   Alexandersen, Soren ^b   Vosloo, Wilna ^a  

^a CSIRO   (Australia)

^b CANADIAN FOOD INSPECTION AGENCY   (Canada)

Author keywords

Foot and mouth disease virus; Heterologous challenge; Sheep; Vaccine efficacy

Indexed keywords

ANTIBODY; FOOT AND MOUTH DISEASE O1 MANISA VACCINE; FOOT AND MOUTH DISEASE VACCINE; STRUCTURAL PROTEIN; UNCLASSIFIED DRUG; VIRUS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DONOR; FOOT AND MOUTH DISEASE; FOOT AND MOUTH DISEASE VIRUS; INOCULATION; MALE; NONHUMAN; NOSE SMEAR; PRIORITY JOURNAL; SALIVA; SEROTYPE; SEROTYPE O FOOT AND MOUTH DISEASE VIRUS; SHEEP; VACCINATION; ANIMAL; CLASSIFICATION; FOOT-AND-MOUTH DISEASE; IMMUNOLOGY; PROCEDURES; TREATMENT OUTCOME;

ANIMALS; FOOT-AND-MOUTH DISEASE; FOOT-AND-MOUTH DISEASE VIRUS; SEROGROUP; SHEEP; TREATMENT OUTCOME; VACCINATION; VIRAL VACCINES;

EID: 84922018225     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.11.043     Document Type: Article

References (37)

1. Brooksby J.B. Portraits of viruses: foot-and-mouth disease virus. Intervirology 1982, 18:1-23.
2. Cartwright B., Morrell D.J., Brown F. Nature of the antibody response to the foot-and-mouth disease virus particle, its 12S protein subunit and the isolated immunizing polypeptide VP1. J Gen Virol 1982, 63:375-381.
3. Samuel A.R., Knowles N.J. Foot-and-mouth disease type O viruses exhibit genetically and geographically distinct evolutionary lineages (topotypes). J Gen Virol 2001, 82:609-621.
4. Nagendrakumar S.B., Srinivasan V.A., Madhanmohan M., Yuvaraj S., Parida S., Di Nardo A., et al. Evaluation of cross-protection between O(1) Manisa and O(1) Campos in cattle vaccinated with foot-and-mouth disease virus vaccine incorporating different payloads of inactivated O(1) Manisa antigen. Vaccine 2011.
5. Vosloo W., Bastos A.D., Sangare O., Hargreaves S.K., Thomson G.R. Review of the status and control of foot and mouth disease in sub-Saharan Africa. Rev Sci. Tech 2002, 21:437-449.
6. Knowles N.J., Samuel A.R. Molecular epidemiology of foot-and-mouth disease virus. Virus Res 2003, 91:65-80.
7. Tekleghiorghis T., Weerdmeester K., van Hemert-Kluitenberg F., Moormann R.J., Dekker A. Comparison of test methodologies for foot-and-mouth disease virus serotype A vaccine matching. Clin Vaccine Immunol CVI 2014, 21:674-683.
8. Ferguson N.M., Donnelly C.A., Anderson R.M. The foot-and-mouth epidemic in Great Britain: pattern of spread and impact of interventions. Science 2001, 292:1155-1160.
9. McFadden A.M., Tsedenkhuu P., Bold B., Purevsuren B., Bold D., Morris R. Epidemiology of the 2010 outbreak of foot-and-mouth disease in Mongolia. Transbound Emerg Dis 2014.
10. Ramanoon S.Z., Robertson I.D., Edwards J., Hassan L., Isa K.M. Outbreaks of foot-and-mouth disease in Peninsular Malaysia from 2001 to 2007. Trop Anim Health Prod 2013, 45:373-377.
11. Burrows R. The persistence of foot-and mouth disease virus in sheep. J Hyg (Lond) 1968, 66:633-640.
12. Salt J.S. The carrier state in foot and mouth disease - an immunological review. Br Vet J 1993, 149:207-223.
13. Doel T.R., Williams L., Barnett P.V. Emergency vaccination against foot-and-mouth disease: rate of development of immunity and its implications for the carrier state. Vaccine 1994, 12:592-600.
14. Parida S., Fleming L., Oh Y., Mahapatra M., Hamblin P., Gloster J., et al. Emergency vaccination of sheep against foot-and-mouth disease: significance and detection of subsequent sub-clinical infection. Vaccine 2008, 26:3469-3479.
15. Salt J.S., Barnett P.V., Dani P., Williams L. Emergency vaccination of pigs against foot-and-mouth disease: protection against disease and reduction in contact transmission. Vaccine 1998, 16:746-754.
16. Cox S.J., Barnett P.V., Dani P., Salt J.S. Emergency vaccination of sheep against foot-and-mouth disease: protection against disease and reduction in contact transmission. Vaccine 1999, 17:1858-1868.
17. Buetre B. Potential socio-economic impacts of an outbreak of foot-and-mouth disease in Australia 2013, ABARES, apo.org.au.
18. Knowles N.J., He J., Shang Y., Wadsworth J., Valdazo-Gonzalez B., Onosato H., et al. Southeast Asian foot-and-mouth disease viruses in Eastern Asia. Emerg Infect Dis 2012, 18:499-501.
19. Sakamoto K. Mechanism of FMD outbreaks and its control in Asian region. J Dis Res 2012, 7:258-263.
20. Park J.H., Lee K.N., Ko Y.J., Kim S.M., Lee H.S., Park J.Y., et al. Diagnosis and control measures of the 2010 outbreak of foot-and-mouth disease A type in the Republic of Korea. Transbound Emerg Dis 2013, 60:188-192.
21. Valdazo-Gonzalez B., Timina A., Scherbakov A., Abdul-Hamid N.F., Knowles N.J., King D.P. Multiple introductions of serotype O foot-and-mouth disease viruses into East Asia in 2010-2011. Vet Res 2013, 44:76.
22. LaRocco M., Krug P.W., Kramer E., Ahmed Z., Pacheco J.M., Duque H., et al. A continuous bovine kidney cell line constitutively expressing bovine alphavbeta6 integrin has increased susceptibility to foot-and-mouth disease virus. J Clin Microbiol 2013, 51:1714-1720.
23. Moniwa M., Embury-Hyatt C., Zhang Z., Hole K., Clavijo A., Copps J., et al. Experimental foot-and-mouth disease virus infection in white tailed deer. J Comp Pathol 2012, 147:330-342.
24. Shaw A.E., Reid S.M., Ebert K., Hutchings G.H., Ferris N.P., King D.P. Implementation of a one-step real-time RT-PCR protocol for diagnosis of foot-and-mouth disease. J Virol Methods 2007, 143:81-85.
25. Mackay D.K., Bulut A.N., Rendle T., Davidson F., Ferris N.P. A solid-phase competition ELISA for measuring antibody to foot-and-mouth disease virus. J Virol Methods 2001, 97:33-48.
26. Cox S.J., Voyce C., Parida S., Reid S.M., Hamblin P.A., Hutchings G., et al. Effect of emergency FMD vaccine antigen payload on protection, sub-clinical infection and persistence following direct contact challenge of cattle. Vaccine 2006, 24:3184-3190.
27. Golde W.T., Pacheco J.M., Duque H., Doel T., Penfold B., Ferman G.S., et al. Vaccination against foot-and-mouth disease virus confers complete clinical protection in 7 days and partial protection in 4 days: use in emergency outbreak response. Vaccine 2005, 23:5775-5782.
28. Madhanmohan M., Nagendrakumar S.B., Kumar R., Anilkumar J., Manikumar K., Yuvaraj S., et al. Clinical protection, sub-clinical infection and persistence following vaccination with extinction payloads of O1 Manisa Foot-and-Mouth Disease monovalent vaccine and challenge in goats and comparison with sheep. Res Vet Sci 2012, 93:1050-1059.
29. Park J.N., Lee S.Y., Chu J.Q., Lee Y.J., Kim R.H., Lee K.N., et al. Protection to homologous and heterologous challenge in pigs immunized with vaccine against foot-and-mouth disease type O caused an epidemic in East Asia during 2010/2011. Vaccine 2014, 32:1882-1889.
30. Callens M., De Clercq K., Gruia M., Danes M. Detection of foot-and-mouth disease by reverse transcription polymerase chain reaction and virus isolation in contact sheep without clinical signs of foot-and-mouth disease. Vet Q 1998, 20(Suppl. 2):S37-S40.
31. Hughes G.J., Mioulet V., Haydon D.T., Kitching R.P., Donaldson A.I., Woolhouse M.E. Serial passage of foot-and-mouth disease virus in sheep reveals declining levels of viraemia over time. J Gen Virol 2002, 83:1907-1914.
32. Madhanmohan M., Nagendrakumar S.B., Srinivasan V.A. Protection against direct in-contact challenge following foot-and-mouth disease vaccination in sheep and goats: the effect on virus excretion and carrier status. Vet Res Commun 2010, 34:285-299.
33. Orsel K., Dekker A., Bouma A., Stegeman J.A., de Jong M.C. Quantification of foot and mouth disease virus excretion and transmission within groups of lambs with and without vaccination. Vaccine 2007, 25:2673-2679.
34. Barnett P.V., Keel P., Reid S., Armstrong R.M., Statham R.J., Voyce C., et al. Evidence that high potency foot-and-mouth disease vaccine inhibits local virus replication and prevents the carrier state in sheep. Vaccine 2004, 22:1221-1232.
35. Lu Z., Cao Y., Guo J., Qi S., Li D., Zhang Q., et al. Development and validation of a 3ABC indirect ELISA for differentiation of foot-and-mouth disease virus infected from vaccinated animals. Vet Microbiol 2007, 125:157-169.
36. Sorensen K.J., Hansen C.M., Madsen E.S., Madsen K.G. Blocking ELISAs using the FMDV non-structural proteins 3D, 3AB, and 3ABC produced in the baculovirus expression system. Vet Q 1998, 20:17-20.
37. Barnett P.V., Carabin H. A review of emergency foot-and-mouth disease (FMD) vaccines. Vaccine 2002, 20:1505-1514.